Top Markets
#1 DogBull DogBull +108.80%
#2 MarsCoin MarsCoin +74.07%
#3 Siacoin Siacoin +56.02%
#4 ADO Protocol ADO Protocol +52.76%
#5 The Bitcoin Bull The Bitcoin Bull +26.51%
#6 Ontology Gas Ontology Gas +22.36%
#7 Useless Coin Useless Coin +16.23%
#8 Apertum Apertum +15.00%
#9 Uniswap Uniswap +13.46%
#10 Arowana Arowana +12.91%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rank in Stocks #15163
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Share Price
$1.98
Market Cap
$368.99M
Change (1 day)
0.90%
Change (1 year)
11.38%
Country
AU
Trade Australian Clinical Labs Limited (ACL)

Category

Healthcare
Number of shares outstanding for Australian Clinical Labs Limited (ACL)
Number of shares outstanding as of September 2026: 0
According to Australian Clinical Labs Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Australian Clinical Labs Limited (ACL) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 371.00M -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 705.30M -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 143.28M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 80.10M -
US